ESTEVE CDMO, a global CDMO specializing in high-quality small-molecule APIs and pharmaceutical intermediates, began a $15.5 ...

With a substantial manufacturing base already locked down in China, CRDMO BioDuro is taking a short jaunt down to Taiwan for its latest drug ingredients production play.  | BioDuro, headquartered in ...

ESTEVE CDMO, the global pure-play CDMO specializing in high-quality small-molecule APIs and pharmaceutical intermediates, today announced that it had commenced a $15.5-million investment to enhance ...

Opens 1600L/1000L reactor stream at Oxford, UK and increases API capacity at Verona, Italy Greenwich, CT, April 2, 2015 - Dr. Jonathan Goldman, CEO, Aptuit LLC, announced that Aptuit has increased its ...

BioDuro and Cenra launch joint venture to expand resilient global API manufacturing capacity: Irvine Californa Thursday, March 5, 2026, 14:00 Hrs [IST] BioDuro, a globally trusted ...

BioDuro, a CRDMO, has established a joint venture with Cenra API Solutions, a pharmaceutical chemical manufacturer in Taiwan.

LONGMONT, Colo.--(BUSINESS WIRE)--Avista Pharma Solutions, Inc. (“Avista Pharma”) has completed facility upgrades that effectively double the company’s API manufacturing capacity at its Longmont, ...

QINGDAO, CHINA, January 19, 2026 /EINPresswire.com/ — As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened ...

The traditional APIs segment accounted for the largest share in 2024, whereas the HPAPI segment is expected to grow at the fastest CAGR over the forecast period. The HPAPI segment is further segmented ...

Dublin, Feb. 10, 2026 (GLOBE NEWSWIRE) -- The "Active Pharmaceutical Ingredients Directory" directory has been added to ResearchAndMarkets.com's offering. Published annually the Active Pharmaceutical ...

ESTEVE CDMO, the global pure-play contract development and manufacturing organization (CDMO) specializing in high-quality ...